Skinvisible (SKVI) Cash & Equivalents (2011 - 2026)
Skinvisible's Cash & Equivalents came in at $3,959 for Q2 2026, compared with $120.00 a year earlier and up 120.2% from the prior quarter.
Powered by 
Analysis
Skinvisible (SKVI) Cash & Equivalents (2011 - 2026) Analysis & Trends
At the end of FY2025, Skinvisible's Cash & Equivalents was $2,620, down 74.7% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of -40.8% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $10,336 in FY2024, $888.00 in FY2023 (-98.9%), $81,378 in FY2022 (+23.2%) and $66,037 in FY2021 (+84.0%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q1 2025.
- Year-over-year, Cash & Equivalents increased in two of the last six quarters, with an average decline of 34.2%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q3 2021 (growth of 316.5%), and the weakest in Q3 2023 (a decline of 99.4%).
- Business Quant data shows SKVI's Cash & Equivalents at $1,798 (Q1 2026), $2,620 (Q4 2025) and $645.00 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Skinvisible | 1.08 Mn | 1.07 Mn | 5,000.00 | 3,959.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3,959.00 |
| Mar 31, 2026 | 1,798.00 |
| Dec 31, 2025 | 2,620.00 |
| Sep 30, 2025 | 645.00 |
| Jun 30, 2025 | 120.00 |
| Mar 31, 2025 | 13,396.00 |
| Dec 31, 2024 | 10,336.00 |
| Sep 30, 2024 | 612.00 |
| Jun 30, 2024 | 6,990.00 |
| Mar 31, 2024 | 8,097.00 |
| Dec 31, 2023 | 888.00 |
| Sep 30, 2023 | 731.00 |
| Jun 30, 2023 | 3,548.00 |
| Mar 31, 2023 | 29,138.00 |
| Dec 31, 2022 | 81,378.00 |
| Sep 30, 2022 | 127,413.00 |
| Jun 30, 2022 | 160,336.00 |
| Mar 31, 2022 | 25,097.00 |
| Dec 31, 2021 | 66,037.00 |
| Sep 30, 2021 | 49,223.00 |
API Access
Skinvisible Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SKVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SKVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SKVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();